Phosphatidylethanolamine: A key player in lung disease

Abstract

Phosphatidylethanolamine (PE) is a pivotal glycerophospholipid that constitutes a significant portion of cellular membranes, playing a crucial role in maintaining membrane fluidity, supporting protein integration, and mediating signal transduction. In the lungs, PE is also a key component of pulmonary surfactant, which is essential for preserving alveolar stability and facilitating efficient gas exchange. Recent research has highlighted the association between dysregulated PE metabolism and various lung diseases, such as asthma, pulmonary fibrosis and chronic obstructive pulmonary disease. Nevertheless, the molecular mechanisms underlying these associations remain poorly understood, and the potential of PE as a therapeutic target or biomarker for lung diseases has yet to be fully explored. This review aims to provide a comprehensive overview of the biological functions and biosynthetic pathways of PE, with a particular focus on its roles in pulmonary physiology and pathology. We summarise current findings on PE alterations in different lung diseases and discuss the potential implications of targeting PE metabolism for therapeutic interventions.

Keywords

lung diseases / metabolism / phosphatidylethanolamine

References

[1] Gibellini F, Smith TK. The Kennedy pathway–De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life. 2010; 62: 414-428.

[2] Dawaliby R, Trubbia C, Delporte C, et al. Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells. J Biol Chem. 2016; 291: 3658-3667.

[3] Dowhan W, Bogdanov M. Lipid-dependent membrane protein topogenesis. Annu Rev Biochem. 2009; 78: 515-540.

[4] van den Brink-van der Laan E, Killian JA, de Kruijff B. Nonbilayer lipids affect peripheral and integral membrane proteins via changes in the lateral pressure profile. Biochim Biophys Acta. 2004; 1666: 275-288.

[5] Calzada E, Onguka O, Claypool SM. Phosphatidylethanolamine Metabolism in Health and Disease. Int Rev Cell Mol Biol. 2016; 321: 29-88.

[6] Gok MO, Speer NO, Henne WM, Friedman JR. ER-localized phosphatidylethanolamine synthase plays a conserved role in lipid droplet formation. Mol Biol Cell. 2022; 33: ar11.

[7] Sam PN, Calzada E, Acoba MG, et al. Impaired phosphatidylethanolamine metabolism activates a reversible stress response that detects and resolves mutant mitochondrial precursors. iScience. 2021; 24:102196.

[8] Wu Y, Chen K, Xing G, et al. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Sci Adv. 2019; 5:eaax7525.

[9] van Golde LM. Synthesis of surfactant lipids in the adult lung. Annu Rev Physiol. 1985; 47: 765-774.

[10] Vazquez-de-Lara LG, Tlatelpa-Romero B, Romero Y, et al. Phosphatidylethanolamine induces an antifibrotic phenotype in normal human lung fibroblasts and ameliorates bleomycin-induced lung fibrosis in mice. Int J Mol Sci. 2018; 19:2758

[11] Wang S, Tang K, Lu Y, et al. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clin Chim Acta. 2021; 513: 34-42.

[12] Walkey CJ, Donohue LR, Bronson R, Agellon LB, Vance DE. Disruption of the murine gene encoding phosphatidylethanolamine N-methyltransferase. Proc Natl Acad Sci U S A. 1997; 94: 12880-12885.

[13] Li Z, Agellon LB, Allen TM, et al. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006; 3: 321-331.

[14] Jin XH, Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Discovery and characterization of a Ca2+-independent phosphatidylethanolamine N-acyltransferase generating the anandamide precursor and its congeners. J Biol Chem. 2007; 282: 3614-3623.

[15] Astarita G, Ahmed F, Piomelli D. Identification of biosynthetic precursors for the endocannabinoid anandamide in the rat brain. J Lipid Res. 2008; 49: 48-57.

[16] Menon AK, Stevens VL. Phosphatidylethanolamine is the donor of the ethanolamine residue linking a glycosylphosphatidylinositol anchor to protein. J Biol Chem. 1992; 267: 15277-15280.

[17] Deleault NR, Piro JR, Walsh DJ, et al. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A. 2012; 109: 8546-8551.

[18] Vance JE, Tasseva G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim Biophys Acta. 2013; 1831: 543-554.

[19] Pavlovic Z, Bakovic M. Regulation of Phosphatidylethanolamine Homeostasis—The Critical Role of CTP:phosphoethanolamine Cytidylyltransferase (Pcyt2). Int J Mol Sci. 2013; 14: 2529-2550.

[20] Fullerton MD, Hakimuddin F, Bakovic M. Developmental and metabolic effects of disruption of the mouse CTP: phosphoethanolamine cytidylyltransferase gene (Pcyt2). Mol Cell Biol. 2007; 27: 3327-3336.

[21] Fang H, Wang W, Wang L, et al. Lipidomic profiling of amniotic fluid reveals aberrant fetal lung development and fetal growth disrupted by lipid disorders during gestational asthma. J Pharma Biomed Anal. 2025; 252:116475.

[22] Guan Y, Chen X, Wu M, et al. The phosphatidylethanolamine biosynthesis pathway provides a new target for cancer chemotherapy. J Hepatol. 2020; 72: 746-760.

[23] Yang A, Pantoom S, Wu YW. Elucidation of the anti-autophagy mechanism of the Legionella effector RavZ using semisynthetic LC3 proteins. Elife. 2017; 6:e23905.

[24] Xu Y, Wan W. Acetylation in the regulation of autophagy. Autophagy. 2023; 19: 379-387.

[25] Guagliardo R, Perez-Gil J, De Smedt S, Raemdonck K. Pulmonary surfactant and drug delivery: focusing on the role of surfactant proteins. J Control Release. 2018; 291: 116-126.

[26] Tlatelpa-Romero B, Cazares-Ordonez V, Oyarzabal LF, Vazquez-de-Lara LG. The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases. Int J Mol Sci. 2022; 24: 326.

[27] Mukherjee S, Sheng W, Sun R, Janssen LJ. Ca(2+)/calmodulin-dependent protein kinase IIbeta and IIdelta mediate TGFbeta-induced transduction of fibronectin and collagen in human pulmonary fibroblasts. Am J Physiol Lung Cell Mol Physiol. 2017; 312: L510-L519.

[28] Richard AS, Zhang A, Park SJ, Farzan M, Zong M, Choe H. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proc Natl Acad Sci U S A. 2015; 112: 14682-14687.

[29] Hornburg D, Wu S, Moqri M, et al. Dynamic lipidome alterations associated with human health, disease and ageing. Nat Metab. 2023; 5: 1578-1594.

[30] Yan Z, Chen B, Yang Y, et al. Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions. Nat Microbiol. 2022; 7: 1361-1375.

[31] Gao D, Zhang L, Song D, et al. Values of integration between lipidomics and clinical phenomes in patients with acute lung infection, pulmonary embolism, or acute exacerbation of chronic pulmonary diseases: a preliminary study. J Transl Med. 2019; 17: 162.

[32] Lagrost L, Masson D. The expanding role of lyso-phosphatidylcholine acyltransferase-3 (LPCAT3), a phospholipid remodeling enzyme, in health and disease. Curr Opin Lipidol. 2022; 33: 193-198.

[33] Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017; 13: 81-90.

[34] Magtanong L, Ko PJ, To M, et al. Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. Cell Chem Biol. 2019; 26: 420-432. e429.

[35] Fu G, Guy CS, Chapman NM, et al. Metabolic control of T(FH) cells and humoral immunity by phosphatidylethanolamine. Nature. 2021; 595: 724-729.

[36] van der Veen JN, Kennelly JP, Wan S, Vance JE, Vance DE, Jacobs RL. The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. Biochim Biophys Acta Biomembr. 2017; 1859: 1558-1572.

[37] Wang Y, Hu M, Cao J, et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2024; 188(2): 412-429. e27.

[38] Gunes Gunsel G, Conlon TM, Jeridi A, et al. The arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD. Nat Commun. 2022; 13: 1303.

[39] Yang L, Cao LM, Zhang XJ, Chu B. Targeting ferroptosis as a vulnerability in pulmonary diseases. Cell Death Dis. 2022; 13: 649.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Discovery published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.